The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point of Care Diagnostics (POCD)-Global Market Insights and Sales Trends 2024
Synopsis
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global Point of Care Diagnostics (POCD) market size is expected to reach US$ 34550 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Diagnostics (POCD) in various end use industries. The expanding demands from the Clinics, Hospitals, Assisted Living Healthcare Facilities and Laboratory, are propelling Point of Care Diagnostics (POCD) market. Blood Glucose Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Infectious Diseases Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Diagnostics (POCD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Diagnostics (POCD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Diagnostics (POCD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Diagnostics (POCD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Diagnostics (POCD) covered in this report include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare and Beckman Coulter, etc.
The global Point of Care Diagnostics (POCD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Global Point of Care Diagnostics (POCD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Diagnostics (POCD) market, Segment by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Global Point of Care Diagnostics (POCD) market, by Application
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Diagnostics (POCD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global Point of Care Diagnostics (POCD) market size is expected to reach US$ 34550 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care Diagnostics (POCD) in various end use industries. The expanding demands from the Clinics, Hospitals, Assisted Living Healthcare Facilities and Laboratory, are propelling Point of Care Diagnostics (POCD) market. Blood Glucose Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Infectious Diseases Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care Diagnostics (POCD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care Diagnostics (POCD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care Diagnostics (POCD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care Diagnostics (POCD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care Diagnostics (POCD) covered in this report include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare and Beckman Coulter, etc.
The global Point of Care Diagnostics (POCD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
QIAGEN
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Instrumentation Laboratory
Sekisui Diagnostics
Global Point of Care Diagnostics (POCD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care Diagnostics (POCD) market, Segment by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Global Point of Care Diagnostics (POCD) market, by Application
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care Diagnostics (POCD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point of Care Diagnostics (POCD)
1.1 Point of Care Diagnostics (POCD) Market Overview
1.1.1 Point of Care Diagnostics (POCD) Product Scope
1.1.2 Point of Care Diagnostics (POCD) Market Status and Outlook
1.2 Global Point of Care Diagnostics (POCD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point of Care Diagnostics (POCD) Market Size by Region (2018-2029)
1.4 Global Point of Care Diagnostics (POCD) Historic Market Size by Region (2018-2023)
1.5 Global Point of Care Diagnostics (POCD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point of Care Diagnostics (POCD) Market Size (2018-2029)
1.6.1 North America Point of Care Diagnostics (POCD) Market Size (2018-2029)
1.6.2 Europe Point of Care Diagnostics (POCD) Market Size (2018-2029)
1.6.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2018-2029)
1.6.4 Latin America Point of Care Diagnostics (POCD) Market Size (2018-2029)
1.6.5 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2018-2029)
2 Point of Care Diagnostics (POCD) Market by Type
2.1 Introduction
2.1.1 Blood Glucose Testing
2.1.2 Infectious Diseases Testing
2.1.3 Cardiac Markers Testing
2.1.4 Coagulation Testing
2.1.5 Pregnancy and Fertility Testing
2.1.6 Blood Gas/Electrolytes Testing
2.1.7 Tumor Markers Testing
2.1.8 Urinalysis Testing
2.1.9 Cholesterol Testing
2.1.10 Others
2.2 Global Point of Care Diagnostics (POCD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2018-2023)
2.2.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point of Care Diagnostics (POCD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point of Care Diagnostics (POCD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point of Care Diagnostics (POCD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point of Care Diagnostics (POCD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point of Care Diagnostics (POCD) Revenue Breakdown by Type (2018-2029)
3 Point of Care Diagnostics (POCD) Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Assisted Living Healthcare Facilities
3.1.4 Laboratory
3.2 Global Point of Care Diagnostics (POCD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2018-2023)
3.2.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point of Care Diagnostics (POCD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point of Care Diagnostics (POCD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point of Care Diagnostics (POCD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point of Care Diagnostics (POCD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point of Care Diagnostics (POCD) Revenue Breakdown by Application (2018-2029)
4 Point of Care Diagnostics (POCD) Competition Analysis by Players
4.1 Global Point of Care Diagnostics (POCD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2022)
4.3 Date of Key Players Enter into Point of Care Diagnostics (POCD) Market
4.4 Global Top Players Point of Care Diagnostics (POCD) Headquarters and Area Served
4.5 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
4.6 Competitive Status
4.6.1 Point of Care Diagnostics (POCD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alere
5.1.1 Alere Profile
5.1.2 Alere Main Business
5.1.3 Alere Point of Care Diagnostics (POCD) Products, Services and Solutions
5.1.4 Alere Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.1.5 Alere Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Point of Care Diagnostics (POCD) Products, Services and Solutions
5.2.4 Roche Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Products, Services and Solutions
5.3.4 Abbott Laboratories Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Products, Services and Solutions
5.4.4 Johnson & Johnson Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Siemens Healthcare
5.5.1 Siemens Healthcare Profile
5.5.2 Siemens Healthcare Main Business
5.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Products, Services and Solutions
5.5.4 Siemens Healthcare Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthcare Recent Developments
5.6 Danaher
5.6.1 Danaher Profile
5.6.2 Danaher Main Business
5.6.3 Danaher Point of Care Diagnostics (POCD) Products, Services and Solutions
5.6.4 Danaher Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.6.5 Danaher Recent Developments
5.7 QIAGEN
5.7.1 QIAGEN Profile
5.7.2 QIAGEN Main Business
5.7.3 QIAGEN Point of Care Diagnostics (POCD) Products, Services and Solutions
5.7.4 QIAGEN Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.7.5 QIAGEN Recent Developments
5.8 Bayer Healthcare
5.8.1 Bayer Healthcare Profile
5.8.2 Bayer Healthcare Main Business
5.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Products, Services and Solutions
5.8.4 Bayer Healthcare Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.8.5 Bayer Healthcare Recent Developments
5.9 Beckman Coulter
5.9.1 Beckman Coulter Profile
5.9.2 Beckman Coulter Main Business
5.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Products, Services and Solutions
5.9.4 Beckman Coulter Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.9.5 Beckman Coulter Recent Developments
5.10 Nipro Diagnostics
5.10.1 Nipro Diagnostics Profile
5.10.2 Nipro Diagnostics Main Business
5.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Products, Services and Solutions
5.10.4 Nipro Diagnostics Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.10.5 Nipro Diagnostics Recent Developments
5.11 Bio-Rad Laboratories
5.11.1 Bio-Rad Laboratories Profile
5.11.2 Bio-Rad Laboratories Main Business
5.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Products, Services and Solutions
5.11.4 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.11.5 Bio-Rad Laboratories Recent Developments
5.12 Nova Biomedical
5.12.1 Nova Biomedical Profile
5.12.2 Nova Biomedical Main Business
5.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Products, Services and Solutions
5.12.4 Nova Biomedical Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.12.5 Nova Biomedical Recent Developments
5.13 BioMerieux
5.13.1 BioMerieux Profile
5.13.2 BioMerieux Main Business
5.13.3 BioMerieux Point of Care Diagnostics (POCD) Products, Services and Solutions
5.13.4 BioMerieux Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.13.5 BioMerieux Recent Developments
5.14 Quidel
5.14.1 Quidel Profile
5.14.2 Quidel Main Business
5.14.3 Quidel Point of Care Diagnostics (POCD) Products, Services and Solutions
5.14.4 Quidel Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.14.5 Quidel Recent Developments
5.15 Helena Laboratories
5.15.1 Helena Laboratories Profile
5.15.2 Helena Laboratories Main Business
5.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Products, Services and Solutions
5.15.4 Helena Laboratories Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.15.5 Helena Laboratories Recent Developments
5.16 OraSure Technologies
5.16.1 OraSure Technologies Profile
5.16.2 OraSure Technologies Main Business
5.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Products, Services and Solutions
5.16.4 OraSure Technologies Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.16.5 OraSure Technologies Recent Developments
5.17 Accriva
5.17.1 Accriva Profile
5.17.2 Accriva Main Business
5.17.3 Accriva Point of Care Diagnostics (POCD) Products, Services and Solutions
5.17.4 Accriva Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.17.5 Accriva Recent Developments
5.18 Abaxis
5.18.1 Abaxis Profile
5.18.2 Abaxis Main Business
5.18.3 Abaxis Point of Care Diagnostics (POCD) Products, Services and Solutions
5.18.4 Abaxis Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.18.5 Abaxis Recent Developments
5.19 Chembio Diagnostics
5.19.1 Chembio Diagnostics Profile
5.19.2 Chembio Diagnostics Main Business
5.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Products, Services and Solutions
5.19.4 Chembio Diagnostics Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.19.5 Chembio Diagnostics Recent Developments
5.20 Trinity Biotech
5.20.1 Trinity Biotech Profile
5.20.2 Trinity Biotech Main Business
5.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Products, Services and Solutions
5.20.4 Trinity Biotech Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.20.5 Trinity Biotech Recent Developments
5.21 Instrumentation Laboratory
5.21.1 Instrumentation Laboratory Profile
5.21.2 Instrumentation Laboratory Main Business
5.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Products, Services and Solutions
5.21.4 Instrumentation Laboratory Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.21.5 Instrumentation Laboratory Recent Developments
5.22 Sekisui Diagnostics
5.22.1 Sekisui Diagnostics Profile
5.22.2 Sekisui Diagnostics Main Business
5.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Products, Services and Solutions
5.22.4 Sekisui Diagnostics Point of Care Diagnostics (POCD) Revenue (US$ Million) & (2018-2023)
5.22.5 Sekisui Diagnostics Recent Developments
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point of Care Diagnostics (POCD) Market Dynamics
11.1 Point of Care Diagnostics (POCD) Industry Trends
11.2 Point of Care Diagnostics (POCD) Market Drivers
11.3 Point of Care Diagnostics (POCD) Market Challenges
11.4 Point of Care Diagnostics (POCD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
